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Background: Headache disorders, anxiety and depression – the major disorders of the brain – are highly comorbid
in the western world. Whether this is so in South Asia has not been investigated, but the question is of public-health
importance to countries in the region. We aimed to investigate associations, and their direction(s), between headache
disorders (migraine, tension-type headache [TTH] and headache on ≥15 days/month) and psychiatric manifestations
(anxiety, depression and neuroticism), and how these might affect quality of life (QoL).
Methods: In a nationwide, cross-sectional survey of the adult Nepalese population (N = 2100), trained interviewers
applied: 1) a culturally-adapted version of the Headache-Attributed Restriction, Disability, Social Handicap and Impaired
Participation (HARDSHIP) questionnaire to diagnose headache disorders; 2) a validated Nepali version of the Hospital
Anxiety and Depression Scale (HADS) to detect anxiety (HADS-A), depression (HADS-D) and comorbid anxiety and
depression (HADS-cAD); 3) a validated Nepali version of the Eysenck Personality Questionnaire Revised Short Form-
Neuroticism (EPQRS-N); and 4) the World Health Organization Quality of Life 8-question scale (WHOQOL-8). Associations
with headache types were analysed using logistic regression for psychiatric caseness and linear regression for
neuroticism. Adjustments were made for age, gender, household consumption, habitat, altitude and use of alcohol and
marijuana.
Results: HADS-A was associated with any headache (p = 0.024), most strongly headache on ≥15 days/month (AOR = 3.2)
followed by migraine (AOR = 1.7). HADS-cAD was also associated with any headache (p = 0.050, more strongly among
females than males [p = 0.047]) and again most strongly with headache on ≥15 days/month (AOR = 2.7),
then migraine (AOR = 2.3). Likewise, neuroticism was associated with any headache (p < 0.001), most strongly with
headache on ≥15 days/month (B = 1.6), followed by migraine (B = 1.3). No associations were found between HADS-D
and any headache type, or between TTH and any psychiatric manifestation. Psychiatric caseness of any sort, when
comorbid with migraine or TTH, aggravated the negative impact on QoL (p < 0.001).
Conclusion: Headache disorders are highly comorbid with anxiety and show associations with neuroticism in Nepal,
with negative consequences for QoL. These findings call for reciprocal awareness, and a holistic coordinated approach
to management and in the health service. Care for common headache and common psychiatric disorders should be
integrated in primary care.
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The term “comorbidity” refers to the coexistence of any
additional ailment in a person with an index disease [1].
Headache disorders such as migraine and tension-type
headache (TTH) and psychiatric disorders such as anx-
iety and depression are all very common among general
populations worldwide. Accordingly, some level of co-
morbidity between them will arise by chance. However,
epidemiological studies over 25 years have consistently
indicated that headache disorders and anxiety and de-
pression are excessively comorbid [2–20], with bidirec-
tional [6] or syndromal [7] associations. Although most
such studies have selectively considered migraine [8–11],
some have looked at TTH [12], “chronic daily headache”
(CDH) [13] or headache in general [14]. Furthermore
there are studies showing associations between headache
disorders and neuroticism [21, 22], a personality trait
closely interlinked with psychological distress [23].
Headache disorders, anxiety and depression are col-
lectively viewed as the major disorders of the brain
(MDBs) [24], each occupying a place among the top ten
causes of disability in the world [25, 26]. From a public-
health perspective, worrying consequences for overall
disease burden arise from these disorders being comor-
bid. Firstly, comorbidity increases morbidity, perhaps
synergistically. For example, headache associated with
psychopathology has exaggerated effects on quality of
life (QoL) and disability [23, 27, 28]. Secondly, comorbid
disorders may be mutually aggravating. Again for ex-
ample, comorbid psychiatric illnesses are risk factors for
headache becoming chronic [29]. Thirdly, comorbid
headache and psychiatric disorders pose significant man-
agement challenges: treatment of each may be hindered
by the other, with worse outcomes likely and increased
health-care liabilities [30]. Fourthly, there is the possibility
of causal relationships, in either or both directions.
Most data on this subject come from the western
world. However, MDBs appear to be prevalent and bur-
densome everywhere. The Global Burden of Disease
Study 2013 (GBD2013) extrapolations to South Asia in-
dicated that years of life lost to disability (YLDs) in this
Region from these conditions were in line with global
rankings [25]. Our study from Nepal, the only nation-
wide study in this region so far, showed high prevalences
of both headache and psychiatric disorders, including a
much higher prevalence of migraine than the global
mean [31] and prevalences of anxiety above and of de-
pression at the upper limit of their respective global
ranges [32]. Both anxiety and depression correlated posi-
tively with neuroticism and negatively with QoL [32].
The probability of comorbidity between these disorders
in Nepal, and the implications arising therefrom, are
consequently matters of considerable public-health im-
portance and of interest to health policy.Therefore, our aims were to examine the extent to
which the common headache disorders (migraine, TTH
and the group of headache disorders characterised by
headache occurring on ≥15 days/month) and psychiatric
disorders (anxiety and depression) are comorbid in
Nepal, a country with unique geocultural diversity [33],
and to look also for associations between these headache
disorders and neuroticism. Our objective was to estab-
lish the public-health implications of any associations
discovered. Our purpose was to guide national health
policy.
Methods
Ethics
This study was part of a research project addressing
MDBs in Nepal [33], approved by the Nepal Health
Research Council, the Institutional Review Committee of
Kathmandu University School of Medical Sciences,
Dhulikhel Hospital, and the Regional Committee for
Health and Research Ethics in Central Norway. In-
formed consent was collected from all participants.
Study design and sampling
This was a cross-sectional study in which unannounced
household visits were made during May 2013 by trained
interviewers using structured questionnaires. In order to
obtain a representative sample of the adult general
population of the country, we used a multistage random
cluster sampling technique to select households in all
three physiographic divisions of Nepal, and, within each
division, all five development regions (Far-Western,
Mid-Western, Western, Central and Eastern). From each
household, we randomly selected one adult aged 18–65
years. The details of the sampling and data collection pro-
cedures, including the steps taken to ensure a very high
participation rate, have been published elsewhere [34].
Survey instrument
We used the Headache-Attributed Restriction, Disability,
Social Handicap and Impaired Participation (HARDSHIP)
questionnaire [35], translated and culturally adapted for
Nepal. It included demographic enquiry followed by mod-
ules assessing headache, psychiatric comorbidities, neur-
oticism and QoL.
All parts of the instrument, including these modules,
were interviewer-administered.
Headache enquiry
The screening question asked “Did you have headache in
the last 12 months?” Those who answered “no” were clas-
sified as headache-free and served as the reference group.
Those responding “yes” were asked a series of diagnostic
questions based on the International Classification of
Headache Disorders (ICHD-3 beta) [36]. Participants
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focus only on the most bothersome type in response to
these questions. Diagnoses were made algorithmically.
Participants with headache on ≥15 days/month were first
separated; those who were also overusing acute or symp-
tomatic medication for headache were diagnosed as
probable MOH (pMOH), and the remainder as “other
headache on ≥15 days/month”. To all other participants,
the algorithm applied ICHD-3 beta criteria, with modifica-
tions, in the order: definite migraine, definite TTH, prob-
able migraine, probable TTH. Any remaining cases were
unclassifiable. In the subsequent analyses, definite and
probable migraine were considered together as migraine,
and definite and probable TTH as TTH. This proced-
ure, and the necessary adaptations made to certain of
the ICHD-3 beta criteria, have been described in de-
tail earlier [31].
Assessment of psychiatric comorbidities
Imported as a module into the HARDSHIP question-
naire was a validated Nepali version of the Hospital
Anxiety and Depression Scale (HADS) [37]. This scale
consists of 14 items in two subscales, HADS-Anxiety
and HADS-Depression, each with seven items [38]. Each
item expresses the subjective experience of the respond-
ent in the preceding week, and is rated 0–3 (3 indicating
maximum symptom severity) so that the sum of each
subscale has a potential range of 0–21. In accordance
with the original description of HADS [38] and our val-
idation of the Nepali version [37], a threshold of 11 on
the respective subscale was taken to indicate caseness
for anxiety or depression. Participants scoring above the
threshold on only one subscale were regarded as cases of
anxiety (HADS-A) only or depression (HADS-D) only;
those scoring above 11 on both were regarded as cases
of comorbid anxiety and depression (HADS-cAD).
Assessment of neuroticism
Also imported as a module into the HARDSHIP question-
naire was a similarly validated version of the Eysenck
Personality Questionnaire Revised Short Form-Neuroticism
(EPQRS-N) [39]. It has 12 questions, each with the
response options “no” (scored 0) and “yes” (scored 1) to
assess the degree of neuroticism in a respondent [40]: the
sum of responses has a potential range of 0–12, with
higher values indicating more neuroticism.
Assessment of quality of life
Finally imported into the HARDSHIP questionnaire was
a culturally-adapted version of the World Health
Organization Quality-of-Life 8-question scale WHOQOL-8
[41]. This consists of eight questions addressing perceived
aspects of the respondent’s QoL in four principal domains:
psychological, physical, social and environmental. Eachquestion has five response options on a Likert scale,
scored from 1 (worst) to 5 (best); the summed score has
the potential range of 8–40, with higher scores indicating
better QoL.Statistical analysis
Analyses were carried out using IBM SPSS Statistics 21.
We used logistic regression analysis to examine
associations between headache (all, and its different types:
migraine, TTH or headache on ≥15 days/month) and psy-
chiatric caseness (HADS-A, HADS-D or HADS-cAD).
Both bivariate and multivariate analyses were undertaken
with headache (or its types) as the independent variable;
multivariate analyses were repeated with each of HADS-A,
HADS-D and HADS-cAD as the independent variable.
Odds ratios (ORs) with 95 % confidence intervals (CIs) are
presented as the measure of association.
We used a general linear regression model (GLM) to
identify associations between total neuroticism score
and all headache or its types. The regression coefficient
(B) represents the difference in neuroticism scores be-
tween participants with headache (or a headache type)
and those with no headache (the reference category in
both analyses).
In the logistic regression analyses as well as the
GLM model, we adjusted for age (categorized 18–25,
26–35, 36–45, 46–55, 56–65 years), gender, annual house-
hold consumption (categorized ≤950, 950–1200, >1200
USD/year), habitat (urban versus rural), altitude (<2000
versus ≥2000 m) and the use of alcohol or marijuana (no
versus yes). Potential interactions of headache types with
demographic (age, gender) or environmental (habitat, alti-
tude) factors in the associations with psychiatric caseness
or total neuroticism score were tested by creating an inter-
action term (the product of the two independent variables:
eg, age category*headache type) which was added to the
regression model. If the interaction term reached stat-
istical significance (p < 0.05), subgroup-specific results
were derived.
We compared WHOQOL-8 scores among participants
with each type of headache with or without psychiatric
comorbidity, and among psychiatric cases with or with-
out comorbid headache. We used Student’s t-test to
compare differences in mean scores. We set p < 0.05 as
the level of significance in all analyses.Results
There were 2100 participants, with a participation rate
of 99.6 % (males: 861 [41.0 %]; females: 1239 [59.0 %];
mean age 36.4 ± 12.8 years). The majority (1328; 63.2 %)
were rural inhabitants, and over one fifth (470; 22.4 %)
lived at an altitude of ≥2000 m. Well over one third
(822; 39.1 %) were in the lowest category of annual
Risal et al. The Journal of Headache and Pain  (2016) 17:45 Page 4 of 9household consumption. A detailed description of the
sample characteristics has been reported previously [34].
Having any headache was significantly associated
with HADS-A caseness (17.2 %) compared with hav-
ing no headache (10.5 %; AOR 1.6; 95 % CI: 1.1–2.3;
p = 0.024) (Table 1). In relation to headache types, the
strongest association with HADS-A was observed for
headache on ≥15 days/month (AOR 3.2) followed by mi-
graine (AOR 1.7); there was no significant association be-
tween TTH and HADS-A (Table 1). No interaction effects
were seen with any of the factors analysed.
There were no significant associations between having
headache and HADS-D caseness (Table 2).
Having any headache was significantly associated with
HADS-cAD caseness (7.0 %) compared with having no
headache (3.6 %; AOR 1.9; 95 % CI: 1.0–3.6; p = 0.050)
(Table 3). Again the strongest association with HADS-cAD
was seen for headache on ≥15 days/month (AOR 2.7)
followed by migraine (AOR 2.3), and there was no signifi-
cant association between TTH and HADS-cAD.
In tests for interaction, we found only a weakly signifi-
cant effect of gender (p = 0.047) with any headache. A
subgroup analysis, however, suggested that the associ-
ation of any headache with HADS-cAD was specific to
females (AOR 4.3 [95 % CI: 1.3–13.8] versus AOR 1.0
[95 % CI: 0.4–2.2] in males). Numbers were low in the
reference group in these analyses. No significant interac-
tions were seen with any of the headache types.
Linear regression analysis showed a significant associ-
ation between all headache and neuroticism score (B = 0.9;
95 % CI: 0.5–1.2; p < 0.001). Among headache types, head-
ache on ≥15 days/month showed the strongest association
(B = 1.6; 95 % CI: 0.9–2.2; p < 0.001), followed by migraine
(B = 1.3; 95 % CI: 0.8–1.7; p < 0.001); the association be-
tween TTH and neuroticism was weak, although signifi-
cant (B = 0.4; 95 % CI: 0.02–0.8; p = 0.040). All these
analyses were adjusted for age, gender, household con-
sumption, habitation, altitude and use of alcohol and
marijuana. Tests for interaction revealed no significant ef-
fects with regard to any headache. However, in relation to
migraine, the association with neuroticism demonstratedTable 1 Logistic regression analysis showing association of headach
Headache type HADS-A caseness
n (%)a
No headache (N = 306) 32 (10.5)
Any headache (N = 1794) 308 (17.2)
Migraine (N = 728) 134 (18.4)
Tension-type headache (N = 863) 121 (14.0)
Headache on ≥15 d/m (N = 161) 48 (29.8)
aNumber (n) of cases with anxiety (HADS-A) and their proportion (%) among those
for age, gender, annual household consumption, habitation, altitude and use of alcsome gender-specificity, being stronger among males
(B = 1.9; 95 % CI: 1.3–2.5) than females (B = 0.8; 95 %
CI: 0.1–1.4).
Tables 4 and 5 summarise the data from Tables 1, 2
and 3, presenting them from a clinical management
perspective: what was the probability (expressed as a
percentage and AOR) that a patient with either headache
(of a specific type) or psychiatric disorder (as HADS
caseness) had the other as a comorbid condition?
HADS-A was the most prevalent HADS caseness co-
morbid with each of the headache types: a patient with
headache on ≥15 days/month had almost 30 % probability
(AOR 3.2) of also having HADS-A. Migraine was the most
prevalent headache comorbid with each of HADS-A,
HADS-D and HADS-cAD: a patient with HADS-cAD
had 46.7 % probability (AOR 2.5) of also having migraine.
Tables 6 and 7 show how the effects of comorbid
headache and HADS caseness interacted on QoL, being
additive (reducing WHOQOL score) in almost all cases.
The only exceptions were that the presence or absence
of TTH made little difference to QoL in those with
HADS-A or HADS-cAD. In general, the additive effects
of comorbid HADS caseness were highly significant;
those of HADS-cAD were strongest and those of
HADS-A least strong. None of the effects of the head-
ache types were significant although, apart from those of
TTH, they were consistent; headache on ≥15 days/
month had, numerically, the strongest effect (Table 7).
Discussion
This is the first nationwide, population-based survey in
any country of South Asia to explore the comorbidity of
headache and psychiatric disorders, which are both
highly prevalent in Nepal [31, 32]. Comorbidity occurred
more than was expected by chance, at least with regard
to migraine and headache on ≥15 days/month on the
one hand, and HADS-A and HADS-cAD on the other,
the associations thereby indicated (with AORs in the
range 1.7–3.2) likely to be bidirectional. There were also
significant associations between headache, especially head-
ache occurring on ≥15 days/month, and neuroticism.e disorders with anxiety (HADS-A)
p
OR [95 % CI] AOR [95 % CI]
Reference
1.8 [1.2–2.6] 1.6 [1.1–2.3] 0.024
1.9 [1.3–2.9] 1.7 [1.1–2.6] 0.013
1.4 [0.9–2.1] 1.3 [0.8–1.9] 0.29
3.6 [2.2–5.9] 3.2 [1.9–5.4] <0.001
(N) with the headache type; OR: odds ratio, AOR: adjusted odds ratio (adjusted
ohol and marijuana), d/m: days/month
Table 2 Logistic regression analysis showing association of headache disorders with depression (HADS-D)
Headache type HADS-D caseness p
n (%)a OR [95 % CI] AOR [95 % CI]
No headache (N = 306) 15 (4.9) Reference
Any headache (N = 1794) 94 (5.2) 1.1 [0.6–1.9] 1.2 [0.6–2.0] 0.66
Migraine (N = 728) 44 (6.0) 1.3 [0.7–2.3] 1.3 [0.7–2.3] 0.49
Tension-type headache (N = 863) 36 (4.2) 0.8 [0.5–1.6] 0.9 [0.5–1.8] 0.91
Headache on ≥15 d/m (N = 161) 11 (6.8) 1.4 [0.6–3.2] 1.5 [0.6–3.4] 0.38
aNumber (n) of cases with depression (HADS-D) and their proportion (%) among those (N) with the headache type; OR: odds ratio, AOR: adjusted odds ratio
(adjusted for age, gender, annual household consumption, habitation, altitude and use of alcohol and marijuana), d/m: days/month
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HADS-D, and none between TTH and any HADS case-
ness. Additive and possibly synergistic effects of comorbid
headache and HADS caseness were evident on QoL,
highly significantly so when migraine or TTH was the
index disorder and HADS caseness the comorbid
disorder.
Before considering the implications of these findings,
we would compare them with others as a test of veracity;
but as we have noted, there are none from this Region.
Outside South Asia, most studies exploring psychiatric
associations with headache disorders have focused on
migraine [3–11]. A Zürich cohort study first demon-
strated strong relationships between migraine and both
anxiety and depression [3], which were subsequently re-
ported in the United States (US) [4, 9] and Canada [42].
Other US studies found that people with migraine had
high levels of neuroticism [43, 44]. In Nepal, we found
strong associations between migraine and HADS-A,
HADS-cAD and neuroticism, but not HADS-D.
There is relatively little evidence regarding psychiatric
associations with episodic TTH [45]. A large Swiss epi-
demiological study found no associations with depressive
or anxiety disorders [7], and neither did we. Episodic
TTH is usually a less painful disorder than migraine,
and less troublesome since it lacks the range of associ-
ated symptoms that contribute to the burden of mi-
graine [35]. Hence people with episodic TTH may notTable 3 Logistic regression analysis showing association of headach
Headache type HADS-cAD caseness
n (%)a
No headache (N = 306) 11 (3.6)
Any headache (N = 1794) 126 (7.0)
Migraine (N = 728) 64 (8.8)
Tension-type headache (N = 863) 42 (4.9)
Headache on ≥15 d/m (N = 161) 17 (10.6)
aNumber (n) of cases with comorbid anxiety and depression (HADS-cAD) and their
AOR: adjusted odds ratio (adjusted for age, gender, annual household consumptionexpress the same extent of subjective emotional experi-
ences as those with migraine [46].
People with chronic TTH, on the other hand, demon-
strate strong psychiatric associations [47]: in the US, al-
most half had either a depressive or an anxiety disorder
[48] while those in a Norwegian study had high levels of
neuroticism [22]. We did not analyse chronic TTH spe-
cifically because it could not reliably be diagnosed by lay
interviewers using a questionnaire [35], but among our
participants with other headache on ≥15 days/month
would have been some with this disorder. The category
of headaches occurring on ≥15 days/month corresponds
with what is elsewhere referred to as “CDH” [49], which
has been associated with high frequencies of both de-
pressive and anxiety symptoms [13, 50]. We found, in
the Nepalese population, that headache on ≥15 days/
month was associated with HADS-A, HADS-cAD and
neuroticism, but not HADS-D.
Our findings, therefore, are not entirely in accord with
others regarding depression. The explanation may be
methodological. We found no association between
HADS-D and any headache type, in line with French
[27] and Norwegian studies [51] that also used HADS to
establish psychiatric caseness. The studies from
Switzerland [3], the US [4] and Canada [42], which
found strong associations between depression and head-
ache, instead used structured interviews based on
Diagnostic and Statistical Manual (DSM) criteria [52]. Ae disorders with comorbid anxiety and depression (HADS-cAD)
p
OR [95 % CI] AOR [95 % CI]
Reference
2.0 [1.1–3.8] 1.9 [1.0–3.6] 0.050
2.6 [1.3–4.9] 2.3 [1.2–4.4] 0.016
1.4 [0.7–2.7] 1.4 [0.7–2.8] 0.34
3.2 [1.4–6.9] 2.7 [1.2–6.1] 0.014
proportion (%) among those (N) with the headache type; OR: odds ratio,
, habitation, altitude and use of alcohol and marijuana), d/m: days/month
Table 4 Prevalence of psychiatric disorder among participants with headache, by headache type
Headache type HADS-A caseness
(N = 340)
HADS-D caseness
(N = 109)
HADS-cAD caseness
(N = 137)
n (%) AOR [95 % CI] n (%) AOR [95 % CI] n (%) AOR [95 % CI]
Migraine (N = 728) 134 (18.4) 1.7 [1.1–2.6] 44 (6.0) 1.3 [0.7–2.3] 64 (8.8) 2.3 [1.2–4.4]
Tension-type headache (N = 863) 121 (14.0) 1.3 [0.8–1.9] 36 (4.2) 0.9 [0.5–1.8] 42 (4.9) 1.4 [0.7–2.8]
Headache on ≥15 d/m (N = 161) 48 (29.8) 3.2 [1.9–5.4] 11 (6.8) 1.5 [0.6–3.4] 17 (10.6) 2.7 [1.2–6.1]
AOR: adjusted odds ratio (multivariate logistic regression analysis, using participants with no headache as reference and adjusted for age, gender, household
consumption, habitation, altitude and use of alcohol and marijuana), d/m: days/month
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findings using the self-administered Patient Health
Questionnnaire-9 (PHQ-9) [54], as did another US study
[48] using the Beck Depression Inventory (BDI) [55].
Cultural factors determining how moods are expressed
[56] may contribute: in many Asian countries, depres-
sion is often manifested somatically [57, 58], while
HADS does not capture the somatic domains of depres-
sion so well [38]. HADS may therefore underestimate
any association of depression alone with headache.
However, as was pointed out in a recent review [20]
and revealed in the French study [27], depression in mi-
graine rarely occurs alone but is almost always comorbid
with anxiety. A stronger association of migraine with
combined anxiety-depression than with either independ-
ently was seen in the early Zürich study [3], and similar
findings in relation to the other headache types came
later in Norway [51]. In our study, HADS-cAD occurred
twice as often among all headache sufferers and those
with migraine, and almost three times in those with
headache on ≥15 days/month. Hence the association of
headache with depression in our population, though not
apparent in HADS-D, may have manifested in HADS-
cAD. There was, however, a gender influence in this associ-
ation: for any headache, the association with HADS-cAD
appeared specific to females (AOR 4.3 versus 1.0 in males).
Summarising these arguments, we believe use of
HADS – a screening rather than diagnostic instrument
for depression – is valid among people with headache al-
though it may underestimate caseness prevalence. We
could not establish any association between headacheTable 5 Prevalence of headache among participants with psychiatri
HADS caseness Migraine
(N = 728)
Ten
(N
n (%) AOR [95 % CI] n (
HADS-A (N = 340) 134 (39.4) 1.8 [1.2–2.7] 121
HADS-D (N = 109) 44 (40.4) 1.3 [0.7–2.4] 36
HADS-cAD (N = 137) 64 (46.7) 2.5 [1.2–4.8] 42
AOR: adjusted odds ratio (multivariate logistic regression analysis, using participant
household consumption, habitation, altitude and use of alcohol and marijuana), d/mdisorders and HADS-D in Nepal, but this limitation
should be taken into account.
We also note other limitations. It is a general limitation
of cross-sectional studies that, while associations can be
demonstrated, causality cannot. However, public-health
purposes are served in the first instance by uncovering
these relationships, which have important policy implica-
tions; subsequent research can investigate causation. It is
a limitation of HADS that it cannot go beyond detecting
caseness of anxiety or depression, which encompass het-
erogeneous mental disorders. This renders it difficult to
identify and make provision in health-service planning for
issues that might be related to particular types of these
disorders. By a similar token, our headache diagnostic
questionnaire captured episodic migraine and TTH, while
all chronic cases were subsumed under headache on
≥15 days/month [35]. Comorbidities associated with these
subtypes were likely to be different in view of their high-
frequency, long-duration, intractable symptoms coupled
with problems in management, but the prevalence of each
would have been about 1 % or less. Categorically assessing
these multiple types and subtypes would have been a
cumbersome exercise requiring much greater investment.
We believe that our approach, with simple validated
interviewer-administered culturally-validated instruments,
was a more practical option in a population with high
illiteracy, and it best served our public-health purpose.
Furthermore, our study had notable strengths: tried and
tested methodology [33–35, 59], large sample size, high
participation rate and good representativeness of the
diverse population of Nepal [33, 34].c disorder, by HADS caseness
sion-type headache
= 863)
Headache on ≥15 d/m
(N = 161)
%) AOR [95 % CI] n (%) AOR [95 % CI]
(35.6) 1.2 [0.8–1.8] 48 (14.1) 3.2 [1.9–5.5]
(33.0) 0.9 [0.5–1.9] 11 (10.1) 1.1 [0.5–2.8]
(30.7) 1.4 [0.7–2.9] 17 (12.4) 2.8 [1.2–6.5]
s with no psychiatric disorder as reference and adjusted for age, gender,
: days/month
Table 6 Quality of life (WHOQOL scores) among participants with headache, by headache type, with and without comorbid
psychiatric disorder
Headache type WHOQOL score (mean ± SD)
HADS-A caseness
(N = 340)
HADS-D caseness
(N = 109)
HADS-cAD caseness
(N = 137)
Present Absent p* Present Absent p* Present Absent p*
Migraine (N = 728) 25.7 ± 4.1 26.9 ± 3.9 <0.001 24.6 ± 2.9 26.9 ± 3.9 <0.001 22.7 ± 3.6 27.1 ± 3.7 <0.001
Tension-type headache (N = 863) 27.2 ± 3.8 28.4 ± 3.7 <0.001 24.9 ± 3.2 28.4 ± 3.7 <0.001 24.4 ± 3.2 28.4 ± 3.6 <0.001
Headache on ≥15 d/m (N = 161) 25.1 ± 4.2 26.2 ± 3.9 0.10 24.0 ± 3.2 25.9 ± 4.1 0.11 21.6 ± 3.4 26.4 ± 3.8 <0.001
*Student’s t-test, d/m: days/month
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From the public-health perspective, there is reason for
alarm in the high prevalences of these MDBs in Nepal.
We found a clear negative impact on QoL in people with
headache and comorbid psychiatric disorder. GBD2013
provides disability weights for these disorders [25],
which, multiplied by prevalence, yield estimates of dis-
ability burden. Migraine, MOH, depression and anxiety
are all in the top 20 causes of YLDs globally [25], while
all seem to be more prevalent in Nepal than their re-
spective global means [31, 32]. These facts, together with
evidence of excessive comorbidity between headache dis-
orders and anxiety, and indications of aggravated burden
when they are comorbid, signal an urgent need for ac-
tion backed by health policy. The global context is not
good, either for headache, which is undertreated every-
where [60] (a failure that should not discourage attempts
at remediation [26]), or for psychiatric disorders, for
which only a minority of affected people receive ad-
equate treatment in most countries around the world
[61]. In Nepal, an underdeveloped country with multiple
adversities [33], the challenges brought forward by these
comorbid conditions are considerable; this resource-
deficient country is not prepared to cope with them.
From the clinical perspective, patients with headache dis-
orders can be expected to have an excess of psychiatric
manifestations, and vice versa. Physicians in Nepal treating
headache patients should be looking out among them for
anxiety and depression as potentially aggravating comorbidTable 7 Quality of life (WHOQOL scores) among participants with H
HADS caseness WHOQOL score (mean ± SD)
Migraine
(N = 728)
Tensio
(N = 86
Present Absent p* Presen
HADS-A (N = 340) 25.7 ± 4.1 26.5 ± 2.8 0.30 27.2 ±
HADS-D (N = 109) 24.6 ± 2.9 26.5 ± 3.9 0.055 24.9 ±
HADS-cAD (N = 137) 22.7 ± 3.6 24.2 ± 3.2 0.21 24.4 ±
*Student’s t-test, d/m: days/monthfactors likely to hinder management. Moreover, psychia-
trists and others treating depression and anxiety can expect
to encounter migraine and headache on ≥15 days/month
at high levels. We summarise this as a need for reciprocal
awareness.
We propose that a coordinated effort offers a solution
from both perspectives – public-health and clinical. It re-
quires training of health-care providers encountering
headache patients to think beyond the somatic dimension:
screening for both anxiety and depression, and collaborat-
ing with mental-health personnel in patient education on
lifestyle, psychological treatment and behavioural strat-
egies, may be appropriate options in addition to offering
usual pharmacological interventions. This already happens
to an extent in some cities where headache patients may
be referred directly to psychiatrists, but these are a small
minority. In the rural areas and in the high hills, such re-
ferrals are generally not possible. In these areas, and in the
cities also, most headache care is and should be provided
in primary care, for reasons related both to logistics and
cost [60], as well as because it is feasible. In primary care
is also where most depression and anxiety are encoun-
tered [62]. Bringing the management of common head-
ache and common psychiatric disorders together under
one primary-care roof, supported by educational initiatives
and referral channels to specialist services, appears to be
good health policy. We recommended its trial implemen-
tation in a circumscribed area as a first step, and enter a
plea for urgency in this action.ADS caseness, with and without comorbid headache
n-type headache
3)
Headache on ≥15 d/m
(N = 161)
t Absent p* Present Absent p*
3.8 26.5 ± 2.8 0.36 25.1 ± 4.2 26.5 ± 2.8 0.096
3.2 26.5 ± 3.9 0.15 24.0 ± 3.2 26.5 ± 3.9 0.094
3.2 24.2 ± 3.2 0.86 21.6 ± 3.4 24.2 ± 3.2 0.060
Risal et al. The Journal of Headache and Pain  (2016) 17:45 Page 8 of 9Conclusion
Headache disorders, highly prevalent in Nepal, are ex-
cessively comorbid with anxiety and associated with
neuroticism, and these relationships aggravate their
negative impact on QoL. These findings call for recipro-
cal awareness, and a holistic coordinated approach to
management and in the health service. Care for common
headache and common psychiatric disorders should be
integrated in primary care.
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